The Enokizumab Biosimilar Anti-IL9 Antibody is a cutting-edge product designed for researchers studying IL9, a crucial cytokine involved in immune responses, inflammation, and allergic reactions. This biosimilar antibody, similar in structure and function to enokizumab, is specifically engineered to target and neutralize IL9, making it a valuable tool in investigating the role of IL9 in various diseases.Developed using advanced biotechnology, the Enokizumab Biosimilar Anti-IL9 Antibody offers high specificity, sensitivity, and consistency in detecting and blocking IL9 activity in human samples. Its versatility in applications such as ELISA, flow cytometry, and immunohistochemistry allows for precise and detailed analysis of IL9 expression and function in different experimental settings.
Given the critical role of IL9 in immune regulation and disease pathogenesis, the Enokizumab Biosimilar Anti-IL9 Antibody holds great potential for research on conditions like asthma, inflammatory bowel disease, and certain types of cancer. By targeting IL9, this antibody opens up new avenues for understanding the mechanisms underlying immune-related disorders and developing novel therapeutic strategies to modulate IL9 signaling pathways.
Product Name:
Enokizumab (Anti-IL9) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0104
Target:
IL9
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
7F3com-2H2, MEDI-528
Description:
Anti-IL9(enokizumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
